3171 results for «3367»
3171 results
Post-procedure complications: leaflet thrombus, hemolytic anemia & more
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
TAVI complex cases: intravascular hemolysis, Heyde syndrome & more
08 Feb 2025 – From PCR Tokyo Valves 2025
This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.
Challenging TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...
Mastering TAV-in-SAV: strategies, challenges and advanced techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to master the ins and outs of TAV-in-SAV? Don’t miss these presentations!
You’ll get expert guidance on evaluating feasibility, choosing the right transcatheter valve and using advanced techniques (valve fracture, leaflet modification, coronary protection...). Plus, you'll dive into multiple real-world case presentations that tackle challenges, share...
TAV-in-SAV - Part 2
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...
Repeat TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of repeat TAVI in this insightful session. Gain a comprehensive understanding of the predicted surge in valve-in-valve volume, the various causes of TAVI dysfunction requiring re-intervention, and the comparative performance of balloon-expandable and self-expandable valves for percutaneous treatment of failed aortic valve...
Mitral and tricuspid intervention
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in mitral and tricuspid valve interventions in this comprehensive session. Gain insights into the impact of respiratory dysfunction on mid-term clinical outcomes after M-TEER, the improvements in left atrial structure and function after mitral valve transcatheter edge-to-edge repair, and the use of...
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
TAVI challenging cases
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this session showcasing challenging TAVI cases and innovative solutions. Witness a successful TAVI case with immediate valve implantation following BAV in a severely calcified aortic valve. Explore a case where VR simulation helped enable easier coronary access during PCI after TAVI. Discover the management...
M-TEER for challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of M-TEER for challenging anatomies. Understand the types of complex anatomies, the associated risks of complications, and learn how to select the appropriate TEER strategy for patients with small left atria, large gaps, and giant left atria. Gain valuable insights to optimize...
Mitral valve interventions cases
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in minimally invasive mitral valve interventions. Explore a range of cutting-edge techniques, including 4D intracardiac echocardiography-guided mitral valve-in-valve procedures, valve-in-ring for severe mitral stenosis, pre-emptive tip to base LAMPOON in valve-in-ring TMVR, and chordal mapping with live multi-planar reconstruction...
Indication and device selection for tricuspid interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to sharpen your skills in selecting the right patients and devices for transcatheter tricuspid interventions? Don’t miss this session!
Learn how to assess anatomical suitability for T-TEER and TTVR, identify patients who may benefit from replacement over repair and explore the latest insights on timing and...
TAVI burning issues
09 Feb 2025 – From PCR Tokyo Valves 2025
This comprehensive session delves into the 'burning issues' in TAVI, covering a wide range of topics. Discover the impact of catheter insertion on left ventricular pacing, the importance of the en-face view for coronary cannulation, comparisons of TAVI valve expansions, indications for left and right ventricular...
Periprocedural management: TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to elevate your expertise in TAVI periprocedural management? This session (in Japanese) is for you!
Discover the essential skills every team member needs for a smooth and successful TAVI procedure. Learn how radiologic technologists optimize imaging, how medical laboratory technologists provide critical real-time data, and how...
Imaging in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in imaging for TAVI, covering a range of topics. Discover insights into clinical outcomes in patients with very low-gradient severe aortic stenosis after TAVI, the influence of TAVI valve differences on long-term outcomes in left ventricular mass index, the...
Hot topics in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest hot topics in TAVI, including the impact of balloon-expandable TAVR valve deformation and calcium distribution on outcomes in bicuspid aortic valve, the outcomes of complex and high-risk vs. standard PCI in TAVI patients, hemodynamic outcomes after TAVI for aortic stenosis with small annuli,...
Valvular interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in valvular interventions in this comprehensive session. Dive into the medical cost analysis of TAVR versus SAVR in Japanese dialysis patients, the long-term outcomes of Myval valve implantation in the pulmonary position, the comparative effectiveness of balloon aortic valvuloplasty techniques,...
Bicuspid and complications
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this comprehensive session exploring the complexities of bicuspid aortic valve disease and the associated complications. Discover tailored sizing techniques for balloon-expandable valves in type 1 bicuspid, navigate the challenges of TAVR in bicuspid aortic valve type 0 with small annulus and coronary compromise, and...
Combined valve disease
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...
